Theravance Biopharma, Inc. Increase (Decrease) in Inventories
Theravance Biopharma, Inc. (TBPH) reported Increase (Decrease) in Inventories of $1.63 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-02-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2021-02-26
- Theravance Biopharma, Inc. increase (decrease) in inventories for the quarter ending 2018-12-31 was $1.08M, a 75.17% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in inventories for the quarter ending 2018-09-30 was $201.00K, a 91.85% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in inventories for the quarter ending 2018-06-30 was -$20.00K, a 103.14% decline year-over-year.
- Theravance Biopharma, Inc. increase (decrease) in inventories for the quarter ending 2018-03-31 was $371.00K.
- Theravance Biopharma, Inc. increase (decrease) in inventories for fiscal 2018 was $1.63M, a 77.69% decline from fiscal 2017.
- Theravance Biopharma, Inc. increase (decrease) in inventories for fiscal 2017 was $7.30M, a 129.45% increase from fiscal 2016.
- Theravance Biopharma, Inc. increase (decrease) in inventories for fiscal 2016 was $3.18M.
- Theravance Biopharma, Inc. increase (decrease) in inventories for fiscal 2015 was -$1.03M, a 115.54% decline from fiscal 2014.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2018-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $1.28M derived: sum of 2 quarters · filed 2021-02-26 | $1.26M derived: sum of 3 quarters · filed 2021-02-26 | $1.63M 10-K · filed 2021-02-26 |
| 2018-09-30 | $201.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $181.00K derived: sum of 2 quarters · filed 2019-11-08 | $552.00K 10-Q · filed 2019-11-08 | $4.89M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $351.00K 10-Q · filed 2019-08-05 | $4.69M derived: sum of 3 quarters · filed 2020-02-27 | $7.16M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $371.00K 10-Q · filed 2019-05-10 | $4.71M derived: sum of 2 quarters · filed 2020-02-27 | $7.17M derived: sum of 3 quarters · filed 2020-02-27 | $7.81M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $4.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $6.80M derived: sum of 2 quarters · filed 2020-02-27 | $7.44M derived: sum of 3 quarters · filed 2020-02-27 | $7.30M 10-K · filed 2020-02-27 |
| 2017-09-30 | $2.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $3.10M derived: sum of 2 quarters · filed 2018-11-08 | $2.96M 10-Q · filed 2018-11-08 | $4.31M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | $637.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $497.00K 10-Q · filed 2018-08-02 | $1.84M derived: sum of 3 quarters · filed 2019-02-28 | $3.84M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | -$140.00K 10-Q · filed 2018-05-09 | $1.20M derived: sum of 2 quarters · filed 2019-02-28 | $3.20M derived: sum of 3 quarters · filed 2019-02-28 | $3.18M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $3.34M derived: sum of 2 quarters · filed 2019-02-28 | $3.32M derived: sum of 3 quarters · filed 2019-02-28 | $3.18M 10-K · filed 2019-02-28 |
| 2016-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.97M derived: sum of 2 quarters · filed 2017-11-08 | $1.84M 10-Q · filed 2017-11-08 | $926.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$157.00K 10-Q · filed 2017-08-09 | -$1.07M derived: sum of 3 quarters · filed 2018-02-28 | -$828.00K derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$134.00K 10-Q · filed 2017-05-10 | -$1.05M derived: sum of 2 quarters · filed 2018-02-28 | -$805.00K derived: sum of 3 quarters · filed 2018-02-28 | -$1.21M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | -$912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | -$671.00K derived: sum of 2 quarters · filed 2018-02-28 | -$1.07M derived: sum of 3 quarters · filed 2018-02-28 | -$1.03M 10-K · filed 2018-02-28 |
| 2015-09-30 | $241.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$159.00K derived: sum of 2 quarters · filed 2016-11-09 | -$118.00K 10-Q · filed 2016-11-09 | $88.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | -$400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | -$359.00K 10-Q · filed 2016-08-09 | -$153.00K derived: sum of 3 quarters · filed 2017-03-01 | $1.91M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $41.00K 10-Q · filed 2016-05-10 | $247.00K derived: sum of 2 quarters · filed 2017-03-01 | $2.31M derived: sum of 3 quarters · filed 2017-03-01 | $6.05M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $206.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $2.27M derived: sum of 2 quarters · filed 2017-03-01 | $6.01M derived: sum of 3 quarters · filed 2017-03-01 | $6.63M 10-K · filed 2017-03-01 |
| 2014-09-30 | $2.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $5.80M derived: sum of 2 quarters · filed 2015-11-12 | $6.42M 10-Q · filed 2015-11-12 | $6.68M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $4.36M 10-Q · filed 2015-08-13 | $4.62M derived: sum of 3 quarters · filed 2016-03-11 | $4.93M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $617.00K 10-Q · filed 2015-05-13 | $876.00K derived: sum of 2 quarters · filed 2016-03-11 | $1.19M derived: sum of 3 quarters · filed 2016-03-11 | $1.24M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $259.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $568.00K derived: sum of 2 quarters · filed 2016-03-11 | $620.00K derived: sum of 3 quarters · filed 2016-03-11 | $3.10M 10-K · filed 2016-03-11 |
| 2013-09-30 | $309.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $361.00K derived: sum of 2 quarters · filed 2014-11-12 | $2.84M 10-Q · filed 2014-11-12 | |
| 2013-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $2.53M 10-Q · filed 2014-08-14 | ||
| 2013-03-31 | $2.48M 10-Q · filed 2014-06-24 | |||
| 2012-12-31 | $4.82M 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |